EBI-031 is a humanized antibody inhibitor targeting IL-6. It is a non-steroidal anti-inflammatory inhibitor with excellent biological efficacy in treating eye diseases, such as non-infectious uveitis (NIU), retinal vascular diseases, and other conditions, including non-uveitic macular edema and diabetic macular edema.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
